ROS inhibitors NAC and DPI were also demonstrated to have a positive effect in attenuating DSS-induced colitis and colitis-associated colorectal cancer in both mice and humans34,35, indicating that NCF4 might prevent colorectal cancer progression through functions other than ROS alone. Here, NCF4 is linked to colorectal cancer.